Assyro AI

Orange Book product · Generic (ANDA)

AZILSARTAN MEDOXOMIL

AZILSARTAN KAMEDOXOMIL

Generic (ANDA)ANDA 214489TE ABRX LUPIN

At a glance

Jul 20, 2022

Approved

Generic (ANDA)

Application

AB

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Jul 20, 2022

    4 yr ago

  2. Today

Pharmaceutical detail

Active ingredient

AZILSARTAN KAMEDOXOMIL

Strength

EQ 40MG MEDOXOMIL

Dosage form

TABLET

Route

ORAL

TE code

AB

Application

ANDA 214489

Product number

001

Marketing status

RX

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of AZILSARTAN KAMEDOXOMIL

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.